These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3130603)

  • 1. Normal human mesothelial cells and fibroblasts transfected with the EJras oncogene become EGF-independent, but are not malignantly transformed.
    Tubo RA; Rheinwald JG
    Oncogene Res; 1987; 1(4):407-21. PubMed ID: 3130603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
    J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperation between the H-ras oncogene and a truncated derivative of the v-myb oncogene in transformation of hamster embryo fibroblasts.
    Merzak A; Dooghe Y; Pironin M; Perbal B; Vigier P
    Oncogene; 1992 Oct; 7(10):2031-9. PubMed ID: 1408144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-myc oncogene enhances mitogenic responsiveness of diploid human fibroblasts to growth factors but fails to immortalize.
    Brondyk WH; Boeckman FA; Fahl WE
    Oncogene; 1991 Jul; 6(7):1269-76. PubMed ID: 1861869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant transformation of human fibroblasts by a transfected N-ras oncogene.
    Wilson DM; Yang DJ; Dillberger JE; Dietrich SE; Maher VM; McCormick JJ
    Cancer Res; 1990 Sep; 50(17):5587-93. PubMed ID: 2201439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ha-Ras-1 oncogene dosage differentially affects Balb/3T3 cells' growth factor requirement and tumorigenicity.
    Kovary K; Armelin MC; Armelin HA
    Oncogene Res; 1989; 4(1):55-64. PubMed ID: 2654813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive relaxation of Go-arrest controls and altered responsiveness to insulin, EGF and thrombin in CCL39 lung fibroblasts over-expressing myc and ras oncogenes.
    Pichon F; Seuwen K; Pouysségur J; Lagarde AE
    Oncogene; 1988 Oct; 3(4):373-81. PubMed ID: 3078948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ras and neu oncogenes reverse serum inhibition and epidermal growth factor dependence of serum-free mouse embryo cells.
    Shirahata S; Rawson C; Loo D; Chang YJ; Barnes D
    J Cell Physiol; 1990 Jul; 144(1):69-76. PubMed ID: 1973170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant transformation of human fibroblasts by oncogene transfection or carcinogen treatment.
    McCormick JJ; Fry DG; Hurlin PJ; Morgan TL; Wilson DM; Maher VM
    Prog Clin Biol Res; 1990; 340D():195-205. PubMed ID: 2196579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
    Storer RD; Allen HL; Kraynak AR; Bradley MO
    Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation-restoring factor: a low molecular weight secreted factor required for anchorage-independent growth of oncogene-resistant mutant cell lines.
    Yang JJ; Kang JS; Krauss RS
    Oncogene; 1995 Apr; 10(7):1291-9. PubMed ID: 7731679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of growth factors and retroviral oncogenes with mitogenic signal transduction pathways of Balb/MK keratinocytes.
    Falco JP; Taylor WG; Di Fiore PP; Weissman BE; Aaronson SA
    Oncogene; 1988 Jun; 2(6):573-8. PubMed ID: 3290805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of an exogenous c-myc gene is insufficient for transformation and tumorigenic conversion of established fibroblasts.
    Zerlin M; Julius MA; Cerni C; Marcu KB
    Oncogene; 1987 Mar; 1(1):19-27. PubMed ID: 3325875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ha-ras-induced transformed phenotype of rat-1 cells can be suppressed in hybrids with rat embryonic fibroblasts.
    Willecke K; Griegel S; Martin W; Traub O; Schäfer R
    J Cell Biochem; 1987 May; 34(1):23-30. PubMed ID: 3495543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS; Zwiebel JA; Noda M; Bassin RH
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R-Ras promotes tumor growth of cervical epithelial cells.
    Rincón-Arano H; Rosales R; Mora N; Rodriguez-Castañeda A; Rosales C
    Cancer; 2003 Feb; 97(3):575-85. PubMed ID: 12548599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anchorage-independent growth of v-myc-transformed Balb/c 3T3 cells is promoted by platelet-derived growth factor or co-transformation by other oncogenes.
    Vennström B; Bravo R
    Oncogene; 1987; 1(3):271-6. PubMed ID: 3330775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.